Hennion & Walsh Asset Management’s abrdn Life Sciences Investors HQL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-28,224
| Closed | -$402K | – | 781 |
|
|
2022
Q2 | $402K | Sell |
28,224
-713
| -2% | -$10.2K | 0.02% | 538 |
|
|
2022
Q1 | $479K | Buy |
28,937
+63
| +0.2% | +$1.04K | 0.03% | 520 |
|
|
2021
Q4 | $555K | Sell |
28,874
-812
| -3% | -$15.6K | 0.03% | 518 |
|
|
2021
Q3 | $617K | Buy |
29,686
+38
| +0.1% | +$790 | 0.03% | 461 |
|
|
2021
Q2 | $636K | Buy |
29,648
+100
| +0.3% | +$2.15K | 0.03% | 469 |
|
|
2021
Q1 | $582K | Buy |
+29,548
| New | +$582K | 0.04% | 476 |
|